Regenerative medicine company Mesoblast Limited today announced the acquisition of the entire culture-expanded mesenchymal stem cell business of Osiris Therapeutics by the Mesoblast Group.
http://www.drugs.com/news/mesoblast-acquires-osiris-culture-expanded-stem-cell-therapeutic-business-48330.html?
http://www.drugs.com/news/mesoblast-acquires-osiris-culture-expanded-stem-cell-therapeutic-business-48330.html?
No comments:
Post a Comment